A novel taspine analog, HMQ1611, inhibits growth of non-small cell lung cancer by inhibiting angiogenesis

J FolkmanAnti-angiogenesis: a new concept for therapy of solid tumorsAnn Surg175409416197210.1097/00000658-197203000-000145077799

N FerraraVascular endothelial growth factor as a target for anticancer therapyOncologist9210200410.1634/theoncologist.9-suppl_1-2

J FolkmanWhat is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst8246199010.1093/jnci/82.1.41688381

H HirteNovel developments in angiogenesis cancer therapyCurr Oncol165054200910.3747/co.v16i3.44419526086

N FerraraHP GerberJ LeCouterThe biology of VEGF and its receptorsNat Med9669676200310.1038/nm0603-66912778165

KJ KimB LiJ WinerM ArmaniniN GillettHS PhillipsN FerraraInhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivoNature362841844199310.1038/362841a07683111

N FerraraVascular endothelial growth factor: basic science and clinical progressEndocr Rev25581611200410.1210/er.2003-002715294883

H ImotoT OsakiS TagaA OhgamiY IchiyoshiK YasumotoVascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinomaJ Thorac Cardiovasc Surg11510071014199810.1016/S0022-5223(98)70398-89605068

DM ParkinGlobal cancer statistics in the year 2000Lancet Oncol2533543200111905707

DN CarneyLung cancer - time to move on from chemotherapyN Engl J Med346126128200210.1056/NEJM20020110346021111784881

ME HalatschU SchmidtJ Behnke-MurschA UnterbergCR WirtzEpidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumorsCancer Treat Rev327489200610.1016/j.ctrv.2006.01.00316488082

J HardingB BurtnessCetuximab: an epidermal growth factor receptor chimeric human-murine monoclonal antibodyDrugs Today (Barc)41107127200510.1358/dot.2005.41.2.88266215821783

J Glade BenderEM CooneyJJ KandelDJ YamashiroVascular remodeling and clinical resistance to antiangiogenic cancer therapyDrug Resist Updat7289300200415533766

P CarmelietAngiogenesis in life, disease and medicineNature438932936200510.1038/nature0447816355210

D RibattiNovel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathwayCancer Treatment Rev37344352201110.1016/j.ctrv.2011.02.00221435792

AP JekunenKJA KairemoInhibition of malignant angiogenesisCancer Treat Rev23263266199710.1016/S0305-7372(97)90014-19377596

Y ZhangL HeL MengW LuoTaspine isolated from Radix et Rhizoma Leonticis inhibits proliferation and migration of endothelial cells as well as chicken chorioallantoic membrane neovascularisationVascul Pharmacol1481291372008

YM ZhangLC HeHY WangInhibitory effect of taspine on mouse S180 sarcoma and its mechanismZhongguo Zhong Yao Za Zhi329539562007(In Chinese)

Y ZhangL HeY ZhouTaspine isolated from Radix et Rhizoma Leonticis inhibits growth of human umbilical vein endothelial cell (HUVEC) by inducing its apoptosisPhytomedicine151121192008

R GrepinG PagesMolecular mechanisms of resistance to tumor antiangiogenic strategiesJ Oncol2010835680201010.1155/2010/83568020224655

LM EllisEpidermal growth factor receptor in tumor angiogenesisHematol Oncol Clin North Am1810071021200410.1016/j.hoc.2004.06.00215474332

RK JainMolecular regulation of vessel maturationNat Med9685693200310.1038/nm0603-68512778167

S RousseauF HouleJ LandryJ Huotp38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cellsOncogene1521692177199710.1038/sj.onc.12013809393975